Enovate Biolife Pvt Ltd
6
0
0
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 6 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (6)
A Study to Evaluate the Effect of EnXtra® and EnXtra® + Caffeine on Mental Alertness and Fatigue in Healthy Individuals
Role: collaborator
A Study to Evaluate Efficacy of Investigational Product HeezOn Ultra -1/ HeezOn Ultra-2 on Male Sexual Health
Role: collaborator
A Study to Evaluate Efficacy of IP on Alertness and Mental Fatigue
Role: collaborator
Study to Assess the Effect of OXYJUN on Ejection Fraction and Markers of Cardiovascular Injury
Role: collaborator
Study to Assess the Effect of E-OA-07 on Acute Pain Response in Subjects Suffering From Knee OA
Role: collaborator
A Randomized Double Dummy Double Blind Dose Determining Place-bo Controlled Study to Evaluate Efficacy of Investigational Product E-RH-06 at 2 Dose Levels for the Metabolic Management of Chronic or Recurrent, Non-infective Nasal Congestion With-or-without Rhinorrhea.
Role: lead
All 6 trials loaded